Siga Technologies Inc key statistics and ratios
In fiscal 2025, Siga Technologies Inc had return on equity of 11.2%, an operating margin of 25.1%, debt equal to 0.0% of equity and a current ratio of 11.83. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 100.0% | 80.0% | 93.3% | 88.2% | 87.6% | 90.6% | 87.3% | 77.4% | 68.6% | 54.4% |
| Operating margin | −206.9% | −153.6% | 74.4% | −8.7% | 67.6% | 66.7% | 38.5% | 59.8% | 50.4% | 25.1% | −20.8% |
| Net margin | −264.9% | −295.3% | 88.4% | −27.1% | 45.1% | 52.0% | 30.6% | 48.6% | 42.7% | 24.6% | −5.2% |
| Free-cash-flow margin | −779.6% | −150.7% | 14.4% | −68.2% | 57.2% | 8.6% | 37.6% | 67.7% | 35.1% | 45.6% | −38.2% |
| Return on equity | — | — | — | −7.2% | 49.5% | 45.7% | 19.7% | 37.1% | 28.7% | 11.2% | −1.5% |
| Return on assets | −24.7% | −23.7% | 242.3% | −3.6% | 32.3% | 38.1% | 16.5% | 30.3% | 23.7% | 10.0% | −1.4% |
| Asset turnover | 0.09 | 0.08 | 2.74 | 0.13 | 0.72 | 0.73 | 0.54 | 0.62 | 0.56 | 0.41 | 0.27 |
| Current ratio | 9.74 | 5.49 | 10.70 | 1.96 | 13.70 | 6.85 | 8.63 | 4.42 | 9.12 | 11.83 | 21.72 |
| Debt to equity | — | — | 73.4% | 81.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Interest cover (operating income ÷ interest) | n/m | n/m | 22.9x | n/m | 28.0x | — | — | — | — | — | — |
| Effective tax rate | — | — | −2.5% | — | 23.4% | 22.2% | 23.2% | 22.5% | 22.2% | 23.4% | — |
| R&D as % of revenue | 131.5% | 136.0% | 2.7% | 49.7% | 8.8% | 7.4% | 20.3% | 11.7% | 8.9% | 21.1% | 38.1% |
| SG&A as % of revenue | 91.5% | 100.3% | 2.7% | 49.6% | 11.8% | 13.5% | 31.7% | 15.8% | 18.1% | 22.4% | 37.0% |
| Capital spending as % of revenue | 0.2% | 0.8% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.6% |
| Free cash flow ÷ net income | — | — | 16.3% | — | 126.9% | 16.5% | 122.7% | 139.2% | 82.3% | 185.2% | — |
| Dividends ÷ net income | — | — | — | — | 0.0% | 0.0% | 97.2% | 47.2% | 72.1% | 185.2% | — |
| Dividends and buybacks ÷ free cash flow | — | — | 0.0% | — | 39.9% | 227.4% | 110.4% | 45.6% | 87.6% | 100.0% | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 83.8% | 82.7% | 97.8% | 68.5% | 61.8% | 21.2% | 52.9% | 57.2% |
| Operating margin | 5.4% | 70.1% | −32.0% | 56.3% | −390.2% | −250.4% | −85.2% | 33.9% |
| Net margin | 13.4% | 56.2% | −5.8% | 43.7% | −243.0% | −143.1% | −55.3% | 30.4% |
| Free-cash-flow margin | −74.0% | 69.1% | 99.9% | 77.8% | −385.6% | −445.5% | −138.8% | 37.0% |
| Current ratio | 8.10 | 9.12 | 8.40 | 10.09 | 9.17 | 11.83 | 3.25 | 21.72 |
| R&D as % of revenue | 30.2% | 4.1% | 49.2% | 5.4% | 269.2% | 132.9% | 63.3% | 10.7% |
| SG&A as % of revenue | 48.2% | 8.5% | 80.6% | 6.8% | 182.7% | 138.7% | 74.9% | 12.6% |
Financial health
- Short-term assets cover short-term liabilities $170m of assets due within a year against $8m of liabilities due within a year.
- Short-term assets cover long-term liabilities $170m short-term assets against $3m of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Strong moat
How hard Siga Technologies's competitive advantage looks for rivals to wear away, judged from 9 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 30.7% of total assets over 9 years.
- Pricing power 12 / 20
Gross margin has been a median 85.8%, moving by 12.2 percentage points (standard deviation) across 9 years.
- Durability 10 / 20
Operating margin has been a median 56.3%; its worst year was -260.3%.
- Cash conversion 15 / 20
Free cash flow was positive in 6 of 9 years, at a median 16.1% of revenue.
- Discipline 19 / 20
The diluted share count fell 7.2% over five years; stock-based pay has been a median 2.1% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (76 before it).
Compare with peers
- Tango Therapeutics, Inc. statistics
- Gossamer Bio, Inc. statistics
- Nektar Therapeutics statistics
- Ocular Therapeutix, Inc statistics
- Invivyd, Inc. statistics
Head to head: SIGA vs TNGXGOSS vs SIGANKTR vs SIGAOCUL vs SIGA
More: Biotechnology stocks compared, Health Care sector, rankings of US companies